Topical brimonidine reduces collateral damage caused by laser photocoagulation for choroidal neovascularization

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 243, Issue 9, 2005, Pages 877-880

  Ferencz, Joseph R ^a   Gilady, Gila ^a   Harel, Orly ^a   Belkin, Michael ^b,c   Assia, Ehud I ^a  

^a MEIR MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Choroidal neovascularization; Laserphoto coagulation; Neuroprotection

Indexed keywords

BRIMONIDINE; PLACEBO;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; LASER COAGULATION; MALE; NEUROPROTECTION; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RETINA INJURY; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

ADMINISTRATION, TOPICAL; ADRENERGIC ALPHA-AGONISTS; AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LASER COAGULATION; MALE; NEUROPROTECTIVE AGENTS; OPHTHALMIC SOLUTIONS; PILOT PROJECTS; PROSPECTIVE STUDIES; QUINOXALINES; RETINAL DISEASES; VISUAL ACUITY;

EID: 25844525413     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-005-1160-7     Document Type: Article

References (17)

1. Brancato R, Pece A, Avanza A, Radrizzani E (1990) Photocoagulation scar expansion after laser therapy for choroidal neovascularization in degenerative myopia. Retina 10:239-243
2. Dastgheib K, Bressler SB, Green WR (1993) Clinicopathologic correlation of laser lesion expansion after treatment of choroidal neovascularization. Retina 13:345-352
3. Donello JE, Padillo EU, Webster ML, Wheeler LA, Gil DW (2001) alpha(2)-Adrenoreceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia. J Pharmacol Exp Ther 296:216a-223a
4. Ettaiche M, Fillacier K, Widmann C, Heurteaux C, Lazdunski M (1999) Riluzole improves functional recovery after ischemia in the rat retina. Invest Ophthalmol Vis Sci 40:729-736
5. Evans DW, Hosking SL, Gherghel D, Bartlett JD (2003) Contrast sensitivity improves after brimonidine therapy in primary open angle glaucoma: A case for neuroprotection. Br J Ophthalmol 87:1463-1465
6. Lafuente MP, Villegas-Perez MP, Sobrado-Calvo P, Garcia-Aviles A, Miralles de Imperial J, Vidal-Sanz M (2001) Neuroprotective effects of alpha(2)-selective adrenergic agonists against ischemia-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci 42:2074-2084
7. Levkovitch-Verbin H, Harris-Cerruti C, Groner Y, Wheeler LA, Schwartz M, Yoles E (2000) RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection. Invest Ophthalmol Vis Sci 41:4169-4174
8. Lynch DR, Dawson TM (1994) Secondary mechanisms in neuronal trauma. Curr Opin Neurol 7:510-516
9. Macular Photocoagulation Study Group (1994) Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Arch Ophthalmol 112:500-509
10. Osborne NN, Cazevieille C, Carvalho AL, Larsen AK, DeSantis L (1997) In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent. Brain Res 751:113-123 10.1016/ S0006-8993(96)01393-5
11. Osborne NN, DeSantis L, Bae JH, Ugarte M, Wood JP, Nash MS, Chidlow G (1999) Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina. Exp Eye Res 69:331-342 10.1006/exer.1999.0706
12. Schuman JS, Horwitz B, Choplin NT, David R, Albracht D, Chen K (1997) A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group. Arch Ophthalmol 115:847-852
13. Solberg Y, Rosner M, Turetz J, Belkin M (1997) MK-801 has neuroprotective and antiproliferative effects in retinal laser injuries. Invest Ophthalmol Vis Sci 38:1380-1389
14. Wen R, Cheng T, Li Y, Cao W, Steinberg RH (1996) Alpha 2-adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage. J Neurosci 116:5986-5992
15. Wheeler LA, Gil DW, WoldeMussie E (2001) Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma. Surv Ophthalmol 245[Suppl 3]:S290-294; discussion S295-296
16. WoldeMussie E, Ruiz G, Wijono M, Wheeler LA (2001) Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest Ophthalmol Vis Sci 42:2849-2855 1:STN:280:DC%2BD3MnjvFSltQ%3D%3D
17. Yoles E, Wheeler LA, Schwartz M (1999) Alpha2-adrenoreceptor agonists are neuroprotecrive in a rat model of optic nerve dgeneration. Invest Ophthalmol Vis Sci 40:65-73 1:STN:280:DyaK1M7gtlGjsQ%3D%3D